Kirkland & Ellis represented Recipharm in the transaction.Recipharm, a global contract development and manufacturing organisation (CDMO) and a portfolio company of EQT, executed the acquisitions of Arranta…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
